• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD MEDICAL - DIABETES CARE BD¿ SYRINGE HEPARIN 27GAX1.2 ML; FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD MEDICAL - DIABETES CARE BD¿ SYRINGE HEPARIN 27GAX1.2 ML; FLUSH Back to Search Results
Catalog Number 324701
Device Problem Device Contamination with Chemical or Other Material (2944)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 07/11/2018
Event Type  malfunction  
Manufacturer Narrative
Date of event: unknown.The date received by manufacturer has been used for this field.(b)(6).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that bd¿ syringe heparin 27gax1.2 ml contained plastic like foreign matter.No serious injury or medical intervention reported.
 
Event Description
It was reported that bd¿ syringe heparin 27gax1.2 ml contained plastic like foreign matter.No serious injury or medical intervention reported.
 
Manufacturer Narrative
Correction: due to an it issue beginning on 7/3/2018, previously filed emdrs did not contain required fields.This supplemental emdr is filed to provide the following omitted fields: event attributed to: other.Device single use?: no.Device returned to manufacture: yes.
 
Manufacturer Narrative
Investigation summary: a dhr review was completed and noted one notification [200641509] which did not pertain to this complaint cause.No other issues noted from this review.A complaint history check was performed but this lot number did not provide any information for this complaint.Severity: s2.No other related complaints were found.On 26jul2018, holdrege received one (1) loose 1ml, 1/2in, 26g sanofi pre-fill syringe from reported batch # 6088621.All samples are decontaminated per hstr-17 prior to being evaluated.Upon evaluation by qe ah, the shield was initially removed and a small filament, appearing to be plastic-like, was noted along the outside of the cannula.The material appears to be what is termed "angelhair" within the manufacturing plant.Ftir analysis was completed on the strand of material observed on the cannula shaft.A small portion of this material was removed from the sample and prepared for ftir spectral analysis.The spectral analysis shows that this material is most likely polyethylene mixed with silicone.This indicates that this material is most likely the angel hair condition described below.Angelhair are small filaments of plastic material, generally composed of polyethylene, one of the component materials utilized in manufacturing of the syringes.These filaments are created during transport of components from one area/piece of equipment on the manufacturing floor to another via a pressurized tube transport system called pea-shooting.As plastic components ride through this system, occasionally, filaments, such as are noted within the received sample, can be generated and find their way into the final packaged product.Due to the frequency of occurrence, these filaments can make it through in-process inspections by certified operators, as well as automated systems utilized to inspect components/devices.The syringes undergo a sterilization process, which would include the foreign material, thus, the material represents more a cosmetic issue for the end user.Continuous improvement projects with the plant to help reduce angelhair being generated continue to be evaluated/implemented as deemed appropriate.Based on the investigation, no capa required at this time.
 
Event Description
It was reported that bd¿ syringe heparin 27gax1.2 ml contained plastic like foreign matter.No serious injury or medical intervention reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD¿ SYRINGE HEPARIN 27GAX1.2 ML
Type of Device
FLUSH
Manufacturer (Section D)
BD MEDICAL - DIABETES CARE
1329 west highway 6
holdrege NE 68949
MDR Report Key7735558
MDR Text Key115678654
Report Number1920898-2018-00552
Device Sequence Number1
Product Code NZW
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,other
Type of Report Initial,Followup,Followup
Report Date 08/27/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/31/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date04/30/2021
Device Catalogue Number324701
Device Lot Number6088621
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/09/2018
Date Manufacturer Received07/11/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-